Skip to main content
SpringerLink
Log in

ICER analysis of CGRP inhibitors for migraine prevention

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's Final Report on CGRP Inhibitors for Migraine Prevention Explores Specific Coverage Policy Options in Light of Responsible Manufacturer Pricing. Internet Document : 3 Jul 2018. Available from: URL: https://icer-review.org/announcements/cgrp-final-report/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICER analysis of CGRP inhibitors for migraine prevention. PharmacoEcon Outcomes News 807, 1 (2018). https://doi.org/10.1007/s40274-018-5080-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5080-2

Search

Navigation